Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. National Kinki-Central Hospital for Chest Diseases, Osaka, Japan

Survival: 15.7 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: Japan
City/State/Province: Osaka
Hospital: National Kinki-Central Hospital for Chest Diseases
Journal: Link
Date: 2/2003

Patients: This Phase II study involved 44 patients with advanced (stage IIIB or IV) non-small cell lung cancer. All patients had not received prior chemotherapy.

Treatment: Treatment consisted of three drugs gemcitabine (gemzar) and vinorelbine (navelbine) followed by docetaxel (taxotere).

Toxicity: Toxicities included hematological (grade 3-4). Other grade 3 toxicities included nausea/vomiting, febrile neutropenia, pneumonitis, fatigue, hepatic dysfunction, hyponatremia, hypopotassemia, and hematuria.

Results: Median survival was 15.7 months.

Correspondence: D. Kawahara, MD

E-mail to a Friend Email Physician More Information